According to recent guidelines, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) should be the drugs of first choice for CKD (Kalaitzidis and Elisaf, 2018). The gene discussed is ACE; the disease is chronic kidney disease.